Literature DB >> 18562519

Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Shirin Munir1, Cyril Le Nouen, Cindy Luongo, Ursula J Buchholz, Peter L Collins, Alexander Bukreyev.   

Abstract

Human respiratory syncytial virus (RSV) is the most important agent of serious pediatric respiratory tract disease worldwide. One of the main characteristics of RSV is that it readily reinfects and causes disease throughout life without the need for significant antigenic change. The virus encodes nonstructural protein 1 (NS1) and NS2, which are known to suppress type I interferon (IFN) production and signaling. In the present study, we monitored the maturation of human monocyte-derived myeloid dendritic cells (DC) following inoculation with recombinant RSVs bearing deletions of the NS1 and/or NS2 proteins and expressing enhanced green fluorescent protein. Deletion of the NS1 protein resulted in increased expression of cell surface markers of DC maturation and an increase in the expression of multiple cytokines and chemokines. This effect was enhanced somewhat by further deletion of the NS2 protein, although deletion of NS2 alone did not have a significant effect. The upregulation was largely inhibited by pretreatment with a blocking antibody against the type I IFN receptor, suggesting that suppression of DC maturation by NS1/2 is, at least in part, a result of IFN antagonism mediated by these proteins. Therefore, this study identified another effect of the NS1 and NS2 proteins. The observed suppression of DC maturation may result in decreased antigen presentation and T-lymphocyte activation, leading to incomplete and/or weak immune responses that might contribute to RSV reinfection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562519      PMCID: PMC2519638          DOI: 10.1128/JVI.00630-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

1.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily.

Authors:  L J Zhou; R Schwarting; H M Smith; T F Tedder
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

2.  Apoptosis. The role of the endonuclease.

Authors:  M J Arends; R G Morris; A H Wyllie
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

4.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

5.  Immunity to and frequency of reinfection with respiratory syncytial virus.

Authors:  C B Hall; E E Walsh; C E Long; K C Schnabel
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.

Authors:  B R Murphy; A V Sotnikov; L A Lawrence; S M Banks; G A Prince
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

7.  Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.

Authors:  John A Rutigliano; Barney S Graham
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.

Authors:  Murali Ramaswamy; Lei Shi; Martha M Monick; Gary W Hunninghake; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2004-01-12       Impact factor: 6.914

9.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

10.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.

Authors:  S Becker; J Quay; J Soukup
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

View more
  71 in total

1.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Authors:  Philippa Hillyer; Viraj P Mane; Aaron Chen; Maria B Dos Santos; Lynnsie M Schramm; Rachel E Shepard; Cindy Luongo; Cyril Le Nouën; Lei Huang; Lihan Yan; Ursula J Buchholz; Ronald G Jubin; Peter L Collins; Ronald L Rabin
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

3.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

4.  Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Authors:  Srirupa Chatterjee; Priya Luthra; Ekaterina Esaulova; Eugene Agapov; Benjamin C Yen; Dominika M Borek; Megan R Edwards; Anuradha Mittal; David S Jordan; Parameshwar Ramanan; Martin L Moore; Rohit V Pappu; Michael J Holtzman; Maxim N Artyomov; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

5.  B cells engineered to express pathogen-specific antibodies protect against infection.

Authors:  Howell F Moffett; Carson K Harms; Kristin S Fitzpatrick; Marti R Tooley; Jim Boonyaratanakornkit; Justin J Taylor
Journal:  Sci Immunol       Date:  2019-05-17

6.  Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.

Authors:  Jingjing Pei; Nicole D Wagner; Angela J Zou; Srirupa Chatterjee; Dominika Borek; Aidan R Cole; Preston J Kim; Christopher F Basler; Zbyszek Otwinowski; Michael L Gross; Gaya K Amarasinghe; Daisy W Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

7.  Evaluation of pneumonia virus of mice as a possible human pathogen.

Authors:  Linda G Brock; Ruth A Karron; Christine D Krempl; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

8.  Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.

Authors:  Cyril Le Nouën; Philippa Hillyer; Eric Levenson; Craig Martens; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

9.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

10.  Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.

Authors:  Yuru Liu; Debra L Haas; Spencer Poore; Sanjin Isakovic; Michelle Gahan; Suresh Mahalingam; Zhen F Fu; Ralph A Tripp
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.